Provectus Biopharmaceuticals Email Format
Biotechnology ResearchTennessee, United States2-10 Employees
Provectus Biopharmaceuticals is a biotechnology research company focused on developing therapies for cancer, including skin, liver, and breast cancers. Its investigational drug PV-10 is described as an ablative immunotherapy under investigation for solid tumors, reflecting a clinical research orientation rather than a marketed product. The company serves the oncology field and aims to address treatment options for cancer patients through immunotherapy approaches. Based in Knoxville, Tennessee, Provectus Biopharmaceuticals operates with a small team and has pursued activities such as expanding its offices in Knoxville and preparing for a 2026 stockholders’ meeting at its planned headquarters. In addition to oncology, the company has announced related ventures and partnerships, including collaborations and launches in ophthalmology and infectious keratitis, indicating a broader focus within biopharmaceutical development.